JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8717 THZ2
1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥28.3 mg/mL
A3197 AT7519 Hydrochloride

Target: Cyclin-Dependent Kinases

Summary: Multi-CDK inhibitor

≥29.93 mg/mL
A3266 BS-181

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor,highly selective

Soluble in DMSO
A3294 CDK9 inhibitor
1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK9 inhibitor

Soluble in DMSO
A3336 CVT-313
1 Citation

Target: Cyclin-Dependent Kinases

Summary: Cdk2 inhibitor

≥20 mg/mL
A3417 Flavopiridol

Target: Cyclin-Dependent Kinases

Summary: Pan-cdk inhibitor

insoluble in H2O; ≥40.2 mg/mL
B4754 LDC000067
2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK9 inhibitor, novel and highly specific

insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
A8885 Ro 3306
4 Citation

Target: Cyclin-Dependent Kinases

Summary: An ATP-competitive, potent CDK1 inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
A8736 THZ531

Target: Cyclin-Dependent Kinases

Summary: CDK12 and CDK13 covalent inhibitor

≥55.8 mg/mL
A8882 THZ1
12 Citation

Target: Cyclin-Dependent Kinases

Summary: Covalent CDK7 inhibitor,potent and selective

≥28.3 mg/mL